Literature DB >> 11185684

Influence of Iodixanol-270 and Iopentol-150 on the microcirculation in man: influence of viscosity on capillary perfusion.

S Spitzer1, W Münster, R Sternitzky, R Bach, F Jung.   

Abstract

UNLABELLED: PURPOSE,
MATERIAL AND METHODS: The aim of this study was to investigate the influence of direct intraarterial application of the contrast agents Iodixanol-270 and Iopentol-150 on the capillary perfusion. This was accomplished through continuous recording of the capillary perfusion in the nailfold capillaries of the right hand before and after a bolus injection of 20 ml of contrast agent into the right axillary artery.
RESULTS: After injecting 20 ml of Iodixanol-270, which has a high viscosity compared to the plasma viscosity, a statistically significant decrease in the erythrocyte velocity of 60.8% from 0.439+/-0.273 mm/s to 0.172+/-0.090 mm/s was observed already 10 s after the injection (p = 0.0001). The decreased velocity was maintained until the end of the observation period of 6 min. In contrast to this finding, no change in the erythrocyte velocity was observed after injection of 20 ml of the low-viscous Iopentol-150 (p = 0.1508).
CONCLUSIONS: The erythrocyte velocity in cutaneous capillaries therefore strongly depends on the viscosity of the contrast agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11185684

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  3 in total

Review 1.  [Optimal x-ray contrast media for ambulatory coronary angiography from the microcirculatory point of view].

Authors:  R Bach; F Jung
Journal:  Herz       Date:  1998-02       Impact factor: 1.443

2.  Two cases of iodixanol-induced pancreatitis.

Authors:  Mufaddal F Kheda; Harold M Szerlip
Journal:  NDT Plus       Date:  2008-06-02

3.  Effect of radiographic contrast media on the spectrin/band3-network of the membrane skeleton of erythrocytes.

Authors:  Ralf-Peter Franke; Tim Scharnweber; Rosemarie Fuhrmann; Folker Wenzel; Anne Krüger; Christof Mrowietz; Friedrich Jung
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.